Kasumi Haruta is a seasoned research analyst with extensive experience in the pharmaceutical sector, currently working at UBS since September 2023. Prior employment includes a role at Credit Suisse as a Pharma/Healthcare analyst and a position at Money Forward, Inc. focusing on corporate planning and venture capital. Haruta also worked at Deutsche Bank as an equity research associate in the machinery sector and held various analyst and internship positions in the fixed income division at Morgan Stanley, client service at Western Asset Management, and consulting with Nomura Research Institute. Educationally, Haruta holds a Master of Engineering in Computer Science and Communication Engineering and a Bachelor of Engineering in Life Science and Biomedical Life Science, both from Waseda University.